[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![NeuroscienceNew Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::32302688.png) Neuroscience News [@NeuroscienceNew](/creator/twitter/NeuroscienceNew) on x 504.5K followers
Created: 2025-07-18 17:50:45 UTC

Innovative Therapies Help Restore Vision Loss in Macular Degeneration

Age-related macular degeneration (AMD) has long been a leading cause of vision loss, but exciting new treatments are changing the landscape. 

FDA-approved complement inhibitors, pegcetacoplan and avacincaptad pegol, slow the progression of dry AMD’s geographic atrophy by targeting inflammation. 

In wet AMD, faricimab offers longer-lasting relief with fewer injections thanks to its dual-targeting mechanism. 

Emerging options like gene therapy, stem cell therapy, and photobiomodulation could further expand patient choices. 

These innovations aim to improve outcomes while reducing treatment burden. 

Yet challenges, such as rare side effects, remind clinicians to proceed carefully.

![](https://pbs.twimg.com/media/GwKG6-8XIAAzTRQ.jpg)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946266405868880144/c:line.svg)

**Related Topics**
[$issc](/topic/$issc)
[advanced micro devices](/topic/advanced-micro-devices)
[stocks technology](/topic/stocks-technology)

[Post Link](https://x.com/NeuroscienceNew/status/1946266405868880144)